<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38075566</PMID><DateRevised><Year>2023</Year><Month>12</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2307-8960</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>33</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>26</Day></PubDate></JournalIssue><Title>World journal of clinical cases</Title><ISOAbbreviation>World J Clin Cases</ISOAbbreviation></Journal><ArticleTitle>Prolonged impacts of COVID-19-associated cystitis: A study on long-term consequences.</ArticleTitle><Pagination><StartPage>7987</StartPage><EndPage>7993</EndPage><MedlinePgn>7987-7993</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.12998/wjcc.v11.i33.7987</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The Coronavirus Disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 virus is an international health concern with substantial morbidity and mortality. COVID-associated cystitis (CAC), presents as new onset or exacerbated urinary symptoms, resembling overactive bladder (OAB) symptoms.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To examines the long-term outcomes of patients with CAC in the context of Long COVID.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A cohort of 350 patients admitted to Detroit Hospitals with COVID-19 between May and December 2020, displaying CAC symptoms following discharge, was prospectively followed. Initial urologic evaluations occurred at 10-14 wk and were repeated at 21-28 mo post-discharge. Symptoms were managed conservatively, employing behavioral modifications and standard OAB medications. Participants completed surveys assessing urinary symptoms and quality of life (QoL) at both time points. The primary outcome was the Urology Care Foundation Overactive Bladder Assessment Tool.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">87% of the final cohort (<i>n</i> = 310) reported symptom improvement at 21-28 mo post-discharge. Patients with new onset CAC symptoms showed a median decrease of 9-10 points in OAB and QoL scores, while those with existing symptoms experienced a decrease of 6 points. Overall, 95.4% of patients with new onset symptoms reported symptom improvement at follow-up, contrasting with 60.7% among those with existing symptoms.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study presents the first long-term follow-up of adult patients with CAC, revealing a promising prognosis with conservative management measures in the context of Long COVID. These findings provide reassurance to patients regarding symptom resolution and underscore the need for further research into this evolving aspect of COVID-19's impact on urological health.</AbstractText><CopyrightInformation>&#xa9;The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wittenberg</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Urology, Wayne State University School of Medicine, Detroit, MI 48201, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vercnocke</LastName><ForeName>Jack</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Urology, Wayne State University School of Medicine, Detroit, MI 48201, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chancellor</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Urology, Beaumont Hospital, Royal Oak, MI 48067, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhar</LastName><ForeName>Sorabh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Infectious Disease, Wayne State University School of Medicine, Detroit, MI 48201, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease, John D. Dingell VA Medical Center, Detroit, MI 48201, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease, Detroit Medical Center, Detroit, MI 48201, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liaw</LastName><ForeName>Aron</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Urology, Wayne State University School of Medicine, Detroit, MI 48201, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, John D. Dingell VA Medical Center, Detroit, MI 48201, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucas</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Urology, Wayne State University School of Medicine, Detroit, MI 48201, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, John D. Dingell VA Medical Center, Detroit, MI 48201, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhar</LastName><ForeName>Nivedita</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Urology, John D. Dingell VA Medical Center, Detroit, MI 48201, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, Detroit Medical Center, Detroit, MI 48201, United States. ec0362@wayne.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Clin Cases</MedlineTA><NlmUniqueID>101618806</NlmUniqueID><ISSNLinking>2307-8960</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID associated cystitis</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Overactive bladder</Keyword></KeywordList><CoiStatement>Conflict-of-interest statement: All the authors have no relevant conflict of interests to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>11</Day><Hour>5</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38075566</ArticleId><ArticleId IdType="pmc">PMC10698398</ArticleId><ArticleId IdType="doi">10.12998/wjcc.v11.i33.7987</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang Z, Wang D, Dai Y, Zhu S, Zeng H. Urogenital System Damaging Manifestations of 3 Human Infected Coronaviruses. J Urol. 2021;205:671&#x2013;677.</Citation><ArticleIdList><ArticleId IdType="pubmed">33026922</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashi AH, De la Rosette J, Amini E, Abdi H, Fallah-Karkan M, Vaezjalali M. Urinary Viral Shedding of COVID-19 and its Clinical Associations: A Systematic Review and Meta-analysis of Observational Studies. Urol J. 2020;17:433&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pubmed">32888186</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamb LE, Dhar N, Timar R, Wills M, Dhar S, Chancellor MB. COVID-19 inflammation results in urine cytokine elevation and causes COVID-19 associated cystitis (CAC) Med Hypotheses. 2020;145:110375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7644255</ArticleId><ArticleId IdType="pubmed">33213997</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: An overview. Diabetes Metab Syndr. 2021;15:869&#x2013;875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang Roberts L, Zwaans BMM, Peters KM, Chancellor M, Padmanabhan P. Incidence of New or Worsening Overactive Bladder Among Patients with a Prior SARS-CoV-2 Infection: A Cohort Study. Eur Urol Open Sci. 2022;46:68&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9554342</ArticleId><ArticleId IdType="pubmed">36245790</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamb LE, Timar R, Wills M, Dhar S, Lucas SM, Komnenov D, Chancellor MB, Dhar N. Long COVID and COVID-19-associated cystitis (CAC) Int Urol Nephrol. 2022;54:17&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8597545</ArticleId><ArticleId IdType="pubmed">34787782</ArticleId></ArticleIdList></Reference><Reference><Citation>Mumm JN, Osterman A, Ruzicka M, Stihl C, Vilsmaier T, Munker D, Khatamzas E, Giessen-Jung C, Stief C, Staehler M, Rodler S. Urinary Frequency as a Possibly Overlooked Symptom in COVID-19 Patients: Does SARS-CoV-2 Cause Viral Cystitis? Eur Urol. 2020;78:624&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236674</ArticleId><ArticleId IdType="pubmed">32475747</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiryaki S, Egil O, Birbilen AZ, Buyukcam A. COVID-19 associated lower urinary tract symptoms in children. J Pediatr Urol. 2022;18:680.e1&#x2013;680.e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9444586</ArticleId><ArticleId IdType="pubmed">36153241</ArticleId></ArticleIdList></Reference><Reference><Citation>Welk B, Richard L, Braschi E, Averbeck MA. Is coronavirus disease 2019 associated with indicators of long-term bladder dysfunction? Neurourol Urodyn. 2021;40:1200&#x2013;1206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8242545</ArticleId><ArticleId IdType="pubmed">33942372</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan VW, Chiu PK, Yee CH, Yuan Y, Ng CF, Teoh JY. A systematic review on COVID-19: urological manifestations, viral RNA detection and special considerations in urological conditions. World J Urol. 2021;39:3127&#x2013;3138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7251800</ArticleId><ArticleId IdType="pubmed">32462305</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin W, Fan J, Hu LF, Zhang Y, Ooi JD, Meng T, Jin P, Ding X, Peng LK, Song L, Tang R, Xiao Z, Ao X, Xiao XC, Zhou QL, Xiao P, Zhong Y. Single-cell analysis of angiotensin-converting enzyme II expression in human kidneys and bladders reveals a potential route of 2019 novel coronavirus infection. Chin Med J (Engl) 2021;134:935&#x2013;943.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8078266</ArticleId><ArticleId IdType="pubmed">33879756</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhawan A, Ganduboina R, Dutta P, Gandrakota G, Kumar Y, Palagati K, Avvaru SN, Sreekumar A, Mylavarapu S, Nizami A, Babu AT, Alam M. COVID-associated cystitis: the culprit behind the bladder woes post-COVID infection? A review. Int Urol Nephrol. 2023;55:2367&#x2013;2372.</Citation><ArticleIdList><ArticleId IdType="pubmed">37410305</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar R, Rathi H, Haq A, Wimalawansa SJ, Sharma A. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19. Virus Res. 2021;292:198235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7680047</ArticleId><ArticleId IdType="pubmed">33232783</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhar N, Dhar S, Timar R, Lucas S, Lamb LE, Chancellor MB. De Novo Urinary Symptoms Associated With COVID-19: COVID-19-Associated Cystitis. J Clin Med Res. 2020;12:681&#x2013;682.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7524562</ArticleId><ArticleId IdType="pubmed">33029276</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochon PA, Mashari A, Cohen A, Misra A, Laxer D, Streiner DL, Clark JP, Dergal JM, Gold J. The inclusion of minority groups in clinical trials: problems of under representation and under reporting of data. Account Res. 2004;11:215&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">15812967</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>